purpos
studi
evalu
diagnost
perform
novel
excitationbas
assay
arcdia
laboratori
turku
finland
antigen
detect
respiratori
virus
versu
realtim
polymeras
chain
reaction
pcr
maripoc
assay
multiplex
realtim
pcr
techniqu
perform
nasopharyng
sampl
pediatr
patient
suspicion
acut
respiratori
infect
admit
children
hospit
spain
octob
januari
total
sampl
studi
sensit
specif
confid
interv
maripoc
assay
respiratori
syncyti
viru
rsv
influenza
viru
ifv
ifvb
human
metapneumoviru
hmpv
adenoviru
adv
respect
maripoc
assay
highli
specif
method
simultan
detect
respiratori
virus
sensit
rang
moder
high
rsv
moder
ifv
hmpv
low
adv
acut
respiratori
infect
particular
confin
lower
respiratori
tract
lead
caus
childhood
mortal
morbid
worldwid
madhi
klugman
diseas
burden
respiratori
infect
young
associ
substanti
consumpt
healthcar
resourc
develop
countri
lower
respiratori
tract
infect
describ
common
diseas
children
admit
hospit
wherea
highli
recurr
infect
upper
respiratori
tract
trigger
larg
number
visit
pediatr
practic
emerg
depart
tregon
schwarz
frequent
detect
virus
acut
respiratori
infect
includ
adenoviru
adv
bocaviru
bov
coronaviru
cov
enteroviru
ev
human
metapneumoviru
hmpv
influenza
viru
ifv
parainfluenza
viru
piv
rhinoviru
rv
respiratori
syncyti
viru
rsv
regardless
caus
agent
symptom
respiratori
infect
due
virus
similar
differ
virus
also
overlap
bacteri
respiratori
infect
make
etiolog
diagnosi
even
challeng
major
respiratori
infect
children
viral
origin
empir
antibiot
treatment
basi
clinic
suspicion
imprecis
may
also
caus
global
emerg
resist
pathogen
jacob
earli
accur
detect
viral
bacteri
agent
orient
time
specif
treatment
well
reduc
antibiot
misus
spread
hospitalacquir
respiratori
infect
benefit
would
deriv
improv
clinic
outcom
also
effect
util
healthcar
resourc
barenfang
et
al
bonner
et
al
doan
et
al
current
method
earli
detect
respiratori
virus
includ
rapid
antigen
detect
test
particularli
use
immunochromatographi
molecular
techniqu
base
polymeras
chain
reaction
pcr
rapid
antigen
detect
test
describ
simpl
specif
method
especi
suitabl
viral
detect
point
care
takahashi
et
al
nonetheless
test
modest
highli
variabl
sensit
avail
limit
number
common
viral
target
contrast
pcr
becom
refer
method
diagnos
viral
respiratori
infect
due
high
sensit
high
specif
mahoney
separ
laboratori
room
prevent
cross
contamin
consequ
perform
pcr
typic
remain
central
refer
laboratori
case
may
easili
access
prompt
diagnosi
assay
arcdia
laboratori
turku
finland
present
antigen
detect
test
rapid
multipl
diagnost
target
respiratori
virus
streptococcu
pneumonia
singl
nasopharyng
aspir
sampl
swab
point
care
test
base
fluoresc
detect
result
format
immunocomplex
mabagmab
monoclon
antibodyantigenlabel
monoclon
antibodi
polystyren
microparticl
use
solid
phase
fluoresc
detect
proprietari
separationfre
excit
techniqu
proport
analyt
concentr
maripoc
assay
provid
randomaccess
fulli
autom
sampl
process
multianalysi
capabl
minim
handson
oper
high
throughput
et
al
koskinen
et
al
object
present
studi
determin
perform
characterist
maripoc
assay
versu
multiplex
realtim
pcr
techniqu
luminex
xtag
rvp
fast
assay
abbot
laboratori
wiesbaden
germani
anyplex
ii
seegen
inc
seoul
korea
consid
refer
diagnost
methodolog
clinic
laboratori
referr
children
hospit
inform
could
interest
assess
accuraci
maripoc
assay
simultan
identif
common
respiratori
virus
earli
stage
infect
studi
includ
excess
nasopharyng
aspir
sampl
avail
molecular
microbiolog
laboratori
children
hospit
sant
joan
de
routin
analys
multipl
viral
profil
octob
januari
first
subset
fresh
sampl
prospect
analyz
maripoc
assay
anyplex
ii
assay
second
subset
fresh
sampl
analyz
luminex
xtag
rvp
fast
assay
prospect
frozen
storag
defrost
retrospect
analysi
maripoc
assay
data
result
pcr
assay
prospect
regist
link
sampl
identif
number
demograph
epidemiolog
data
link
sampl
specimen
collect
childrenadolesc
year
admit
hospit
nonspecif
suspicion
acut
respiratori
infect
set
size
tertiarycar
children
hospit
locat
metropolitan
area
barcelona
spain
provid
healthcar
coverag
pediatr
popul
children
search
pathogen
cover
respiratori
virus
could
detect
techniqu
adv
hmpv
ifva
ifvb
rsv
specif
virus
target
pcr
techniqu
cov
ev
rv
bov
note
sinc
luminex
xtag
rvp
fast
assay
could
detect
ev
rv
separ
posit
evrv
sampl
techniqu
retest
anyplex
ii
assay
identifi
caus
viru
perform
maripoc
assay
carri
accord
manufactur
instruct
follow
step
transfer
ml
aspir
sampl
ml
buffer
sampl
tube
vortex
oper
wait
vortex
oper
centrifug
insert
sampl
tube
maripoc
analyz
autom
analysi
molecular
amplif
preced
rnadna
viru
extract
magna
pure
compact
instrument
roch
laboratori
basel
switzerland
use
sampl
elut
util
rvp
fast
assay
plate
format
anyplex
ii
assay
accord
case
manufactur
instruct
pcr
test
includ
intern
control
check
potenti
inhibit
substanc
present
specimen
could
invalid
result
addit
maripoc
assay
also
includ
intern
control
assess
integr
step
statist
analysi
conduct
use
statist
packag
social
scienc
softwar
spss
version
ibm
corp
chicago
il
usa
perform
characterist
determin
util
conting
tabl
enter
categor
variabl
posit
neg
result
maripoc
pcr
test
type
viru
global
set
virus
includ
maripoc
viral
panel
extend
pcr
viral
panel
chisquar
test
fisher
exact
test
use
compar
categor
variabl
confid
interv
ci
set
signific
pvalu
statist
analysi
total
excess
nasopharyng
aspir
sampl
avail
studi
eight
exclud
maripoc
assay
inhibit
sampl
pcr
test
sampl
final
studi
compris
sampl
total
sampl
posit
result
neg
result
pcr
test
set
virus
maripoc
panel
sampl
posit
result
pcr
also
test
posit
maripoc
assay
test
neg
number
viral
agent
identifi
pcr
virus
frequent
detect
among
sampl
rsv
n
rv
n
wherea
hmpv
n
cov
n
bov
n
ifvb
n
n
found
lower
rate
presenc
adv
n
ev
n
ifva
n
n
minor
sampl
collect
viral
coinfect
detect
sampl
rsv
present
coinfect
sampl
tabl
record
distribut
respiratori
virus
detect
pcr
techniqu
overal
sensit
maripoc
assay
virus
includ
panel
ci
assay
sensit
detect
rsv
lower
valu
found
ifva
ifvb
hmpv
particularli
adv
overal
specif
assay
ci
measur
maripoc
perform
characterist
detail
tabl
compar
analysi
subset
specimen
process
prospect
retrospect
maripoc
assay
result
overal
sensit
sampl
analyz
prospect
versu
analyz
retrospect
p
overal
specif
subset
respect
p
result
studi
suggest
maripoc
assay
highli
specif
virus
cover
test
show
variabl
sensit
rang
moder
high
rsv
worryingli
low
adv
thu
confirm
neg
result
mean
sensit
method
pcr
would
recommend
practic
use
maripoc
assay
clinic
laboratori
environ
high
specif
found
concur
report
previou
evalu
assay
versu
pcr
pediatr
emerg
depart
set
ivaska
et
al
howev
observ
compar
higher
sensit
hmpv
lower
sensit
rsv
ifva
ifvb
adv
studi
hypothes
differ
sensit
evalu
could
deriv
differ
factor
impact
posit
viru
microbiolog
characterist
cours
infect
children
age
refer
pcr
techniqu
use
ohmit
monto
note
sensit
found
rsv
similar
sensit
document
rapid
rsv
test
versu
pcr
studi
children
aslanzadeh
et
al
miernyk
et
al
munjal
et
al
similarli
sensit
assay
ifv
discord
variabl
valu
rang
rapid
ifv
test
children
describ
elsewher
alexand
et
al
cruz
et
al
grijalva
et
al
sandora
et
al
contrast
recent
studi
compar
maripoc
test
direct
antibodi
assay
tuuminen
et
al
report
higher
sensit
rsv
ifva
fact
studi
perform
season
winter
epidem
sever
infect
like
increas
posit
result
may
explain
improv
valu
sensit
describ
studi
pathogen
sensit
hmpv
consider
lower
valu
rang
previous
report
rapid
hmpv
test
compar
pcr
kikuta
et
al
matsuzaki
et
al
likewis
sensit
adv
valu
document
adv
immunochromatograph
test
levent
et
al
interestingli
despit
low
sensit
detect
piv
coverag
viru
could
distinct
featur
maripoc
assay
sinc
knowledg
rapid
antigen
test
target
piv
reach
market
far
turn
uncov
detect
cov
ev
rv
bov
could
consid
drawback
assay
comparison
multiplex
pcr
techniqu
usual
offer
coverag
wider
rang
respiratori
agent
maripoc
assay
prove
robust
sampl
inhibit
compar
number
inhibit
pcr
techniqu
sinc
signific
differ
sensit
specif
deliv
assay
subset
sampl
frozen
storag
test
versu
subset
fresh
sampl
analyz
prospect
preprocess
activ
seem
influenc
result
result
interpret
light
potenti
limit
low
number
sampl
test
posit
ifva
ifvb
adv
piv
pandem
influenza
season
specif
pcr
techniqu
target
ifv
perform
instead
nonspecif
multiplex
pcr
confirm
presenc
suspect
influenza
costeffect
practic
follow
clinic
laboratori
would
explain
ifv
sampl
identifi
posit
studi
case
adv
piv
low
rate
posit
found
relat
virus
may
reflect
less
import
role
epidemiolog
viral
respiratori
infect
geograph
area
line
posit
rate
report
virus
local
studi
et
al
also
import
note
quantiti
abil
detect
virus
antigen
pcr
assay
vari
age
sinc
studi
conduct
laboratori
approach
demograph
data
patient
regist
fact
affect
comparison
result
techniqu
sampl
could
potenti
limit
compar
result
studi
conclus
maripoc
assay
prove
highli
specif
respiratori
virus
includ
panel
appear
show
moder
high
sensit
rsv
neg
result
assay
rest
viral
panel
confirm
perform
sensit
method
avail
clinic
decis
make
oper
perform
costeffect
evalu
would
help
assess
util
maripoc
assay
diagnos
viral
respiratori
infect
current
multiplex
pcr
techniqu
rapid
antigen
detect
test
